Sleep specialists say that sleep apnea is on the rise across the country and can come with a slew of health risks. Mal Parrott was diagnosed at 27, and describes treatment as "life changing." ...

With the global sleep apnea device market valued at $8.52 billion in 2024 and projected to rise to nearly $13 billion by 2030, according to one 2025 report, medical tech companies are developing ...

Obstructive sleep apnea can lead to a range of health problems, and snoring isn’t the only symptom. Here are five odd symptoms of this potentially dangerous condition.

There’s currently no drug approved for the treatment of sleep apnea, but the makers of a new pill are hoping to change that. Researchers at Apnimed, a Massachusetts-based company, have developed ...

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...

The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder.

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The Food and Drug Administration on Friday authorized the use of Zepbound ...